Paul Moss

University of Birmingham - Institute of Immunology and Immunotherapy

Birmingham

United Kingdom

SCHOLARLY PAPERS

5

DOWNLOADS

489

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (5)

1.

Booster Vaccination Strongly Enhances SARS-CoV-2-Specific Antibody and Cellular Responses in Elderly Residents of Care Homes

Number of pages: 20 Posted: 20 Dec 2021
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University College London - Institute for Health Informatics, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University College London - Institute for Health Informatics, University College London - Institute for Health Informatics, University College London - Institute for Health Informatics, University College London - Institute for Health Informatics, UK Health Security Agency, UK Health Security Agency, Health Data Research UK, University College London - Institute for Global Health, University College London - Institute for Health Informatics and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 177 (239,252)

Abstract:

Loading...

SARS-CoV-2, COVID-19, Vaccination, Booster, Care home, Long Term Care Facility (LTCF), Elderly

2.

Impaired Neutralisation of SARS-CoV-2 Delta Variant in Vaccinated Patients With B Cell Chronic Lymphocytic Leukaemia

Number of pages: 26 Posted: 12 Oct 2021
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham, University of Glasgow, University of Glasgow - Centre for Virus Research (CVR), University of Glasgow, University of Glasgow - Centre for Virus Research (CVR), University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham, UK Health Security Agency, University of Birmingham - Cancer Research UK Clinical Trials Unit, University of Birmingham - Cancer Research UK Clinical Trials Unit, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Birmingham - Institute of Cancer and Genomic Sciences, Government of the United Kingdom - Royal Wolverhampton NHS Trust, Barking, Havering and Redbridge University Hospitals NHS Trust - Sandwell and West Birmingham Hospitals NHS Trust, Herefordshire and Worcestershire Health and Care NHS Trust, Government of the United Kingdom - University Hospitals Birmingham, University Hospitals Birmingham - Birmingham Heartlands Hospital and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 152 (271,470)

Abstract:

Loading...

CLL, COVID-19, SARS-CoV-2, Vaccination

3.

Reduced Antibody and Cellular Immune Responses Following Dual COVID-19 Vaccination Within Infection-Naïve Residents of Long-Term Care Facilities

Number of pages: 29 Posted: 09 Dec 2021
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University College London - Institute for Health Informatics, University College London - Institute for Health Informatics, University College London - Institute for Health Informatics, University College London - Institute for Health Informatics, University College London - Institute for Health Informatics, UK Health Security Agency, Health Data Research UK, University College London - Institute for Global Health, University College London - Institute for Health Informatics and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 139 (291,456)

Abstract:

Loading...

Long Term Care Facility, Resident, COVID-19, SARS-CoV-2, Vaccination

4.

Vaccine Subtype and Dose Interval Determine Immunogenicity of Primary Series COVID-19 Vaccines in Older People

Number of pages: 29 Posted: 27 Apr 2022
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Glasgow - Centre for Virus Research (CVR), University of Glasgow - Centre for Virus Research (CVR), University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Glasgow - Centre for Virus Research (CVR), University of Birmingham - Institute of Immunology and Immunotherapy and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 13 (776,987)

Abstract:

Loading...

COVID-19, vaccines, elderly, primary series, BNT162b2, ChAdOx1

5.

The Single Cell Transcriptional Landscape of Esophageal Adenocarcinoma and Its Modulation by Neoadjuvant Chemotherapy

Number of pages: 43 Posted: 07 Jun 2022
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University Hospitals Birmingham NHS Foundation Trust, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 8 (827,502)

Abstract:

Loading...

Esophageal adenocarcinoma, scRNA-seq, regulatory T cell, Cancer-associated fibroblast, plasmacytoid dendritic cell